Similar articles

• Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.

  Freedman AS, Takvorian T, Nadler LM, Anderson KC, Sallan SE, Ritz J. Freedman AS, et al. Cancer Treat Res. 1988;38:265-83. doi: 10.1007/978-1-4613-1713-5_9. Cancer Treat Res. 1988. PMID: 2908599 Review. No abstract available.
• Treatment of murine tumors with lethal doses of dimethylmyleran and autologous bone marrow.

  Floersheim GL. Floersheim GL. Eur J Cancer Clin Oncol. 1981 Aug;17(8):905-12. doi: 10.1016/0014-2964(81)90313-3. Eur J Cancer Clin Oncol. 1981. PMID: 7035181 No abstract available.
• Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice.

  Merino F, Abeyounis CJ, Milgrom F. Merino F, et al. Eur J Cancer (1965). 1979 Jun;15(6):829-35. doi: 10.1016/0014-2964(79)90223-8. Eur J Cancer (1965). 1979. PMID: 499271 No abstract available.
• Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

  Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A; Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ, et al. J Clin Oncol. 2003 Oct 15;21(20):3744-53. doi: 10.1200/JCO.2003.08.054. Epub 2003 Sep 8. J Clin Oncol. 2003. PMID: 12963703
• Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

  Aksentijevich I, Flinn IW. Aksentijevich I, et al. Cancer Control. 2002 Mar-Apr;9(2):99-105. doi: 10.1177/107327480200900202. Cancer Control. 2002. PMID: 12008655 Review.